Free Republic

A sweeping new report from the World Health Organization found that up to four in 10 cancer cases around the globe could be prevented with lifestyle changes. In the large international study, researchers identified 30 modifiable risk factors that fuel the disease — including, for the first time, nine cancer-causing infections. “This is the first global analysis to show how much cancer risk comes from causes we can prevent,” Dr. André Ilbawi, the WHO’s team lead for cancer control and the study’s author, said in a press release. “By examining patterns across countries and population groups, we can provide governments...

Patients with advanced lung cancer who received immunochemotherapy before 15:00 (3 p.m.) had a more delayed disease progression than patients receiving treatment later in the day. The findings, published as part of a randomized phase 3 trial of 210 participants, suggest that scheduling therapy early in the day may offer a simple, cost-neutral way to enhance standard care. Circadian rhythms, the internal 24-hour clock, are known to affect immune cell behavior and responses to treatment. Previous retrospective studies across cancers, such as kidney cancer and malignant melanoma, have hinted that administering immune checkpoint inhibitors earlier in the day might be...

People with compromised liver function may be able to reduce their risk of liver cancer or slow its progression with a simple dietary change: eating less protein. A study has found that low-protein diets slowed liver tumor growth and cancer death in mice, uncovering a mechanism by which a liver's impaired waste-handling machinery can inadvertently fuel cancer. When people consume protein, the nitrogen can be converted into ammonia, a substance that's toxic to the body and brain. A healthy liver typically processes this ammonia into harmless urea, which is excreted via urine. To test whether impaired ammonia processing drives cancer...

A team of researchers have identified a fundamental mechanism that links the 24-hour circadian cycle to the precise repair of DNA breaks. This study, focused on the circadian protein Cryptochrome1 (CRY1), suggests that the time of day when radiotherapy is administered can significantly influence the effectiveness of treatment for certain types of cancer. It is relatively common for cancer cells to be unable to repair their DNA efficiently. Treatments, such as radiotherapy, exploit this by generating DNA breaks that tumor cells are unable to repair. This study shows DNA break repair in human cells exhibits a circadian oscillation. In a...

For decades, pancreatic cancer has been one of medicine's most feared diagnoses. Aggressive, fast moving, and stubbornly resistant to treatment, it has claimed lives with ruthless efficiency. Now, the name Mariano Barbacid is echoing far beyond scientific circles. His latest work is being hailed as one of the most important cancer breakthroughs in years, offering a glimmer of hope against a disease that has defied progress for decades. Who Is Mariano Barbacid Mariano Barbacid was born on 4 October 1949 and built his career at the cutting edge of cancer genetics. He earned his PhD from the Universidad Complutense de...

Pancreatic cancer is one of the most aggressive tumours with the worst prognosis, partly because of the rapid emergence of resistance to treatment. But a new study from the Spanish National Cancer Research Centre (CNIO) reveals that it is possible to eliminate pancreatic tumours in mice and prevent them from recurring using triple combination therapy. "These studies open a way to design new combination therapies that can improve the survival of patients with pancreatic ductal adenocarcinoma," the authors said in a statement. "These results set the direction for the development of new clinical trials, it added. The results, published in...

Scientists have identified why certain lung cancer cells become highly resistant to treatment after developing mutations in a key gene called EGFR (epidermal growth factor receptor). In a study, the researchers reveal a previously unknown survival mechanism and demonstrated that disrupting it can shrink tumors in laboratory models. Lung cancer is the leading cause of cancer deaths globally. Many cases are driven by mutations in the EGFR gene. These mutations are found in up to 40–60% of adenocarcinoma. The researchers screened more than 21,000 genes to identify what protects these mutant proteins from being broken down. They discovered that cancer...

For the first time, most people diagnosed with cancer are expected to live at least five years beyond their diagnosis—a dramatic improvement from previous decades. The improvements detailed in the organization’s Cancer Statistics 2026 report, recently published in CA: A Cancer Journal for Clinicians, highlight significant progress in cancer survival rates in the United States. “Seven in 10 people now survive their cancer five years or more, up from only half in the mid-70s,” Rebecca Siegel, senior scientific director at the American Cancer Society (ACS), said in a press statement. She credited decades of cancer research that have provided doctors...

SNIP The “Dilbert” creator, 68, is reportedly in hospice at his home in Northern California, his first ex-wife, Shelly Miles, told TMZ on Monday. Miles, who was married to the legendary cartoonist from 2006 to 2014, also informed the outlet that Adams began receiving “end-of-life care” at his home last week because his health was declining “rapidly.” Although nurses have reportedly been “coming in and out” around the clock, Miles said that she, her sister and the “Dilbert” creator’s stepdaughter, Savannah, have been helping to care for Adams in his final days.

A global review examining reported cases of cancer following Covid vaccination was published earlier this month, just as the medical journal hosting it was hit by a cyberattack that has since taken the site offline.The study appeared in the peer-reviewed journal Oncotarget on January 3 and was authored by cancer researchers from Tufts University in Boston and Brown University in Rhode Island.In the review, researchers analyzed 69 previously published studies and case reports from around the world, identifying 333 instances in which cancer was newly diagnosed or rapidly worsened within a few weeks following Covid vaccination.The review covered studies from...

A novel tumor suppressor, BATF2, can be silenced by factors in the tumor microenvironment, leading to a reduced immune response in five preclinical models of head and neck cancer, according to researchers. The results demonstrate that glutamine in the tumor microenvironment can cause epigenetic silencing of BATF2, which affects the STING signaling pathway and overall immune response. Lei said, "This study characterizes a novel oral cancer tumor suppressor that drives immune surveillance but is inhibited by high levels of glutamine." BATF2 is a tumor suppressor involved in regulating immune responses, helping to maintain anti-tumor immune surveillance. BATF2 is highly expressed...

Cancer doctors have grown accustomed to good news. Over the past three decades, lung cancer deaths have plummeted by 40%. Breast cancer mortality has dropped 44%. Prostate cancer deaths have fallen by half. Colon cancer, once a leading killer, now claims 50% fewer lives than in 1990. These victories represent billions in research funding, surgical innovations, targeted therapies, and nationwide screening campaigns—the sum total of modern medicine’s war on cancer. Yet one malignancy refuses to follow the script. Pancreatic cancer—the silent executioner lurking behind the stomach, wrapped around vital blood vessels, often symptomless until the final act—is not only resisting...

Dilbert creator Scott Adams has revealed that his health has taken a turn for the worse, though there is still hope he could recover with the help of doctors. As The Gateway Pundit reported, Adams announced earlier this year he had stage 4 prostate cancer that had metastasized to his bones back in May. “I have the same cancer that Joe Biden has,” Adams said at the time. “I also have prostate cancer that has also spread to my bones. I’ve had it longer than he’s had it – well, longer than admitting that he’s had it, so my life...

Israeli researchers have reported a new treatment for advanced‑stage classical Hodgkin lymphoma (a type of cancer of the white blood cells) that achieved a 100% one‑year overall survival rate in a large cohort of patients participating in their program. Israeli researchers have unveiled an innovative treatment for advanced-stage Hodgkin lymphoma that they say resulted in a one-year survival rate of 100 per cent, representing a “true revolution” in caring for people with the disease. While traditionally the management of patients with advanced-stage classical Hodgkin lymphoma has relied exclusively on chemotherapy, the new treatment combines advanced chemotherapy with targeted biological therapy....

There's conspiracy theories, and then theres Patrick Soon-Shiong, the surgeon who owns the LA Times, talking about how he's now seeing spike proteins "from COVID" in the aggressive tumors of his patients. A billionaire oncologist just went on national television and said the words millions have been waiting to hear publicly.Dr. Patrick Soon-Shiong – the surgeon who invented the nanoparticle chemotherapy Abraxane, sold companies for billions, and now owns the LA Times – appeared… pic.twitter.com/ZWA960vha9— Camus (@newstart_2024) November 30, 2025Chris Cuomo: 'When you look in tumors what are you seeing? Dr. Soon-Shiong: 'There's now evidence that when you actually biopsy...

Progress in cutting the global toll of cancer remains painfully slow, but a new blood test has sparked unusual levels of hope. Researchers say it could one day make routine screening far more effective by catching cancers earlier, when treatment has the best chance of saving lives. The Galleri blood test, developed by US firm Grail, is the latest entrant to attract worldwide attention, after early trial results were described as “exciting” by researchers. A press release claims the test, currently being trialled by the NHS, can detect signals from 50 cancers and correctly identify the disease in 62% of...

[H/T ExTexasRedhead]The Nobel prize winning miracle drug Ivermectin works as an antiviral, anticancer, is part of a Lyme Disease cure protocol, and even reverses dementia, all while having a safety profile that is far superior to aspirin or any “vaccine” for that matter.Cancer surgeon Dr. Kathleen Ruddy had the following to say about Ivermectin:Cancer Surgeon: “Ivermectin Is SAFER Than a Sugar Pill” 👁️“You’d have to take a lot to make yourself sick.”Dr. Kathleen Ruddy has also observed multiple late-stage cancer patients make dramatic recoveries after taking ivermectin.Ivermectin is also:• A Nobel Prize-winning discovery (2015)• Recognized, 2nd to penicillin, for having...

Findings are "important milestone" in a field where AI has yet to prove clinical use, expert saysKey Takeaways -In a confirmatory study, AI achieved statistically non-inferior and superior performance in detecting pancreatic cancer compared with a pool of participating radiologists. -At matched sensitivity levels, the AI system reduced the number of false positives compared with radiologists. -AI could help diagnose pancreatic cancer sooner, and more accurately, an expert suggested. -An artificial intelligence (AI) system outperformed radiologists in detecting pancreatic ductal adenocarcinoma (PDAC) on routine CT scans, according to a non-inferiority, confirmatory, observational study. In a testing cohort of 1,130 patients,...

Scientists have uncovered how the gut microbiota help the immune system fight melanoma, explaining why patients with a fiber-rich diet and balanced gut bacteria tend to respond better to cancer immunotherapies. The study shows that molecules produced by gut bacteria upon digestion of dietary fiber can improve the function of cancer-fighting immune cells. The research team found that these digestive by-products influence melanoma progression by naturally boosting killer T cell function in pre-clinical cancer models. "Melanoma patients undergoing immunotherapy can benefit from a fiber-rich diet and previous studies suggested that what we eat affects the immune system. However, how that...

Two FDA-approved drugs for treating prostate cancer may also be effective against acute myeloid leukemia (AML), according to a new study. AML, a cancer of blood and bone marrow, can affect people of all ages but is the most common type of leukemia in adults. The research tested the ability of the two drugs—apalutamide and finasteride—to treat leukemia in experimental models. They found that the drugs were effective in treating mice with AML as well as patient-derived AML cells. K. Sandeep Prabhu said the drugs work by inhibiting the pathway that is activated by dihydrotestosterone—an androgen hormone more potent than...